Biotech entity
Every one of those 1 sits in a single category, pharma. Sildenafil is most often covered alongside FDA, which appears in 1 of these 1 story. The tracked stories average 46 original sources each. Sildenafil appears in 1 tracked Biotech story from March 13, 2026.
Last mentioned: Mar 13, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Sildenafil is most often covered alongside FDA, which appears in 1 of these 1 story. The tracked stories average 46 original sources each. Sildenafil appears in 1 tracked Biotech story from March 13, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Sildenafil. Shared-story counts are live from our verified record — not editorial picks.
A nationwide recall has been issued for a wellness supplement after FDA testing revealed the presence of sildenafil, the active ingredient in Viagra. The undeclared pharmaceutical poses significant health risks, particularly to individuals with cardiovascular conditions taking nitrates.
Sildenafil is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
